NuroPro Diagnostic Blood Test Platform

Amarantus BioScience Holdings, Inc. acquired the IP behind the NuroPro test for Parkinson’s and several other indications in December 2012. A full list of indications covered is below:

1. Parkinson’s disease
2. Alzheimer’s disease
3. Lou Gehrig’s disease (ALS)
4. Neuromuscular disease
5. Breast Cancer
6. Chonic Myelogenous Leukemia